HR 7693
Leo’s Law
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 3:50 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
```json { "summary": "This bill, titled Leo’s Law, extends exclusivity periods for orphan drugs – medications developed to treat rare diseases – by 180 days. These extensions are specifically designed to mitigate the impact of the COVID-19 pandemic on pharmaceutical incentives. The bill applies to drugs submitted during the pandemic and aims to provide additional time for manufacturers to recoup their investment in developing these critical medications. It covers various exclusivity periods related to patents and regulatory approvals.", "keyProvisions": [ "Extends 12-year orphan drug exclusivity by 180 days.", "Extends 5-year exclusivity period for drug approvals by 180 days.", "Extends 3-year exclusivity periods related to specific drug approvals by 180 days.", "Extend
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.